Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
eQ Plc Stock Exchange Release – Changes board/management/auditors2 March 2026 at 9:00 AM Pertti Vanhanen, EMBA, has been appointed Director, International Business, as well as a member of the...
-
Dubai, UAE, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Pepeto has crossed $7.556 million in presale funding and confirmed its positioning as the first dedicated infrastructure layer for the $45 billion...
-
Dubai, UAE, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Pepeto announced today that its presale has officially crossed $7.33 million in total funding. The crypto news comes as XRP surged 9% in a single day...
-
CPAmerica is pleased to welcome Fieldguide, a leading AI-native platform for audit and advisory firms, as a new Preferred Provider for the association.
-
WYOMISSING, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Gaming and Leisure Properties, Inc. (“GLPI”) (NASDAQ: GLPI) today announced the pricing of a public offering of $800,000,000 aggregate principal...
-
Advantage Solutions Inc. announced the appointments of Thomas Turner and Xiaofeng "Frank" Yao to its Board of Directors.
-
SAN FRANCISCO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Baker Street Advisors (“Baker Street” or “the firm”), a leading SEC-registered investment advisor with $20 billion in client assets under advisement,...
-
Transaction diversifies and strengthens global insurance and reinsurance platform Aspen Class A ordinary shares delisted from NYSE TOKYO and HAMILTON, Bermuda, Feb. 24, 2026 (GLOBE NEWSWIRE) --...
-
Acquisition Expected to Increase Annual Dividend to $1.50 Per Share and Generate Levered Returns Exceeding 20 Percent Fort Worth, TX, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Presidio Investment Holdings...
-
Sravan Emany brings capital markets and commercial-stage, rare disease expertise as the Company advances towards commercialization Andrew Miller adds deep clinical development and product approval...